Cor Vasa 2009, 51(1):32-37 | DOI: 10.33678/cor.2009.009

Inflammatory cardiomyopathy: current concepts regarding its diagnosis and treatment

Petr Kuchynka1, Tomáš Paleček1,*, Stanislav Šimek1, Ivana Vítková2, Jana Schramlová3, Dagmar Hulínská3, Viktor Aster4, Gabriela Dostálová1, Sudheera Magage1, Michael Aschermann1, Aleš Linhart1
1 II. interní klinika kardiologie a angiologie
2 Ústav patologie, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy
3 Státní zdravotní ústav
4 III. klinika infekčních a tropických nemocí, Fakultní nemocnice Na Bulovce a 1. lékařská fakulta Univerzity Karlovy, Praha, Česká republika

Inflammatory cardiomyopathy is a term used for myocarditis associated with left ventricular dysfunction. There are many infectious and non-infectious causes of this disease with viral infection being the most common. In order to definitely establish the diagnosis of inflammatory cardiomyopathy, endomyocardial biopsy (EMB) has to be performed. To obtain appropriate diagnostic information, detailed assessment of EMB including histopathological, immunohistochemical and microbiological evaluation should be performed. The results of EMB specimens processed in such a manner may consequently have an impact on the therapeutic strategy in inflammatory cardiomyopathy, when immunosuppressive, antimicrobial or immunomodulatory treatment may be added to conventional therapy.

Keywords: Inflammatory cardiomyopathy; Myocarditis; Endomyocardial biopsy

Published: January 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kuchynka P, Paleček T, Šimek S, Vítková I, Schramlová J, Hulínská D, et al.. Inflammatory cardiomyopathy: current concepts regarding its diagnosis and treatment. Cor Vasa. 2009;51(1):32-37. doi: 10.33678/cor.2009.009.
Download citation

References

  1. Richardson P, Mc Kenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomypathies. Circulation 1996;93:841-2. Go to original source...
  2. Elliot P, Anderson B, Arbustini, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-6. Go to original source... Go to PubMed...
  3. Kühl U, Pauschinger M, Noutsias M, et al. Diagnosis and treatment of patients with virus induced inflammatory cardiomyopathy. Eur Heart J Supplements 2002;4 (Suppl I):173-8. Go to original source...
  4. Bowles NE, Kearney DL, Pauschinger M, et al. Detection of viruses in myocardial tissues by polymerase chain reaction, evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003;42:466-72. Go to original source...
  5. Kühl U, Pauschinger M, Noutsias M, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 2005;111:887-93. Go to original source... Go to PubMed...
  6. Bartůnĕk P, Goričan K, Veiser T, Táborský M, Hulínská D. Significance of Borrelia infection in development of dilated cardiomypathy (a pilot study). Prague Med Rep 2007;108:339-47. Go to PubMed...
  7. Quiros FR, Moralko CA, Casas JP, et al. Charity: Chagas cardiomyopathy bisoprolol intervention study: a randomized double blind force titration controlled study with Bisoprolol in patiens with chronic heart failure secondary to Chagas cardiomyopathy. Trials 2006;7:21. Go to original source... Go to PubMed...
  8. Mason JW. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 2003;60:5-10. Go to original source... Go to PubMed...
  9. Maisch B, Herzum M, Hufnagel G, et al. Immunosuppresive treatment for myocarditis and dilated cardiomyopathy. Eur Heart J 1995;16 (Suppl O): 153-61. Go to original source... Go to PubMed...
  10. Pankuweit S, Portig I, Lottspeich F, et al. Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Coll Cardiol 1997;29:77-84. Go to original source... Go to PubMed...
  11. Aretz HT, Billingham ME, Edward WD, et al. Myocarditis. A histopatologic definition and classification. Am J Cardiovasc Pathol 1987;1:3-14.
  12. Salvi A, Di Lenarda A, Dreas L, et al. Immunosuppressive treatment in myocarditis. Int J Cardiol 1989;22:329-38. Go to original source... Go to PubMed...
  13. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial immunosuppresive therapy for myocarditis. N Engl J Med 1995;333:269-75. Go to original source... Go to PubMed...
  14. Baghman KL. Diagnosis of myocarditis: Death of Dallas Criteria. Circulation 2006;113:593-5. Go to original source... Go to PubMed...
  15. Kühl U, Noutsias M, Seeberg B, et al. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 1996;75:295-330. Go to original source... Go to PubMed...
  16. Kühl U, Toussaint H, Ulrich G, et al. Evaluation of immunohistological data for the diagnosis of myocarditis. In: Schultheiss HP, ed. New concepts of viral heart disease. Berlin, Heidelberg, New York: Springer-Verlag, 1988:325-36. Go to original source...
  17. Kühl U, Noutsias M, Seeberg B, et al. Immunohistological evaluation of myocardial biopsies from patients with dilated cardiomyopathy. J Heart Fail 1994;9:231-45.
  18. Noutsias M, Pauschinger M, Poller WC. Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy. Heart Fail Monit 2003;3:127-35. Go to PubMed...
  19. Satoh M, Akatsu T, Ishikawa Y, et al. Association between toll-like receptor 8 expression and averse clinical outcomes in patients with enterovirus-associated dilated cardiomyopathy. Am Heart J 2007;154:581-8. Go to original source... Go to PubMed...
  20. Pankuweit S, Hufnagel G, Eckhardt H, et al. Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation. Med Klin Munich 1998;93:223-8. Go to original source... Go to PubMed...
  21. Magnani JW, Dec GW. Myocarditis, current trends in diagnosis and treatment. Circulation 2006;113:876-90. Go to original source... Go to PubMed...
  22. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo-controlled study for immunosuppresive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001; 104:39-45. Go to original source... Go to PubMed...
  23. Frustaci A, Chimenti C, Calabrese F, et al. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003;107:857-63. Go to original source... Go to PubMed...
  24. Kühl U, Pauschinger M, Schwimmbeck PL, et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003;107:2793-8. Go to original source... Go to PubMed...
  25. Hess OM, McKenna W, Schultheiss HP. Myocardial disease. In: Camm AJ, Lüscher TF, Serryus PW, ed. The ESC Textbook of Cardiovascular Medicine, 2006:453-515.
  26. Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007;116:2216-33. Go to original source... Go to PubMed...
  27. www.escardio.org/congresses/ESC2008/congress-reports.
  28. www.medscape.com/viewarticle/583383.
  29. Caforio ALP, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002;4:411-7. Go to original source... Go to PubMed...
  30. Jahns R, Boivin V, Hein L, et al. Direct evidence for a β1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004;113:1419-29. Go to original source... Go to PubMed...
  31. Okazaki T, Tanaka Y, Nishio R, et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 2003;9:1477-83. Go to original source... Go to PubMed...
  32. Felix SB, Staudt A, Landsberger M, et al. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 2002;39:646-52. Go to original source... Go to PubMed...
  33. Staudt A, Hummel A, Ruppert J, et al. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J 2006;152:712e1-6. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.